Drug Database
Back to search

Czechia· CZ-0194483

INCRESYNC

A pioglitazone and alogliptin product containing alogliptin benzoate + pioglitazone hydrochloride, registered in Czechia by Takeda Pharma A/S, Vallensbaek Strand. The same ATC class is registered in 9 of our 19 countries.

ATC A10BD09

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedINCRESYNCATCA10BD09REGISTER NO.CZ-0194483PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about alogliptin benzoate + pioglitazone hydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pioglitazone and alogliptin is registered in 9 of 19 countries.

Countries holding a registration under ATC A10BD09 (pioglitazone and alogliptin), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 6 of them publish a price we can compare per daily dose
Search pioglitazone and alogliptin products by name

Pioglitazone and alogliptin · ATC A10BD09

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

SÚKL (Czech Republic)
Active substance
ALOGLIPTIN BENZOATE + PIOGLITAZONE HYDROCHLORIDE
Manufacturer
Takeda Pharma A/S, Vallensbaek Strand
Country
Czechia (CZ)
ATC code
A10BD09
ATC class
Pioglitazone and alogliptin
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Pioglitazone and alogliptin in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pioglitazone and alogliptin products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc43387f-296b-4de0-b751-ef4b14c1dbf2
GET /v1/drugs/fc43387f-296b-4de0-b751-ef4b14c1dbf2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "25MG/30MG",
  "pack_size": "60",
  "substance": "ALOGLIPTIN BENZOATE + PIOGLITAZONE HYDROCHLORIDE",
  "cz_kod_sukl": "0194483",
  "product_type": "CH",
  "substance_codes": "20246,16290",
  "registration_state": "R",
  "registration_number": "EU/1/13/842/024"
}
API referenceMCP serverPlans

See everything about pioglitazone and alogliptin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console